[go: up one dir, main page]

GR3023848T3 - Pharmaceutical composition containing 3-guanidinopropionic acid and pioglitazone glibenclamide or glimepiride. - Google Patents

Pharmaceutical composition containing 3-guanidinopropionic acid and pioglitazone glibenclamide or glimepiride.

Info

Publication number
GR3023848T3
GR3023848T3 GR970401487T GR970401487T GR3023848T3 GR 3023848 T3 GR3023848 T3 GR 3023848T3 GR 970401487 T GR970401487 T GR 970401487T GR 970401487 T GR970401487 T GR 970401487T GR 3023848 T3 GR3023848 T3 GR 3023848T3
Authority
GR
Greece
Prior art keywords
guanidinopropionic acid
pct
pioglitazone
insulin
glimepiride
Prior art date
Application number
GR970401487T
Other languages
English (en)
Inventor
Martin Durham Meglasson
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/751,239 external-priority patent/US6008253A/en
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of GR3023848T3 publication Critical patent/GR3023848T3/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
    • A23L2/52—Adding ingredients
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/64—Sulfonylureas, e.g. glibenclamide, tolbutamide, chlorpropamide
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Mycology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
GR970401487T 1991-08-26 1997-06-19 Pharmaceutical composition containing 3-guanidinopropionic acid and pioglitazone glibenclamide or glimepiride. GR3023848T3 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US75055991A 1991-08-26 1991-08-26
US07/751,239 US6008253A (en) 1991-08-26 1991-08-26 Use of 3-guanidinopropionic acid to increase endurance, stamina and exercise capacity in a mammal
PCT/US1992/006776 WO1993003724A1 (en) 1991-08-26 1992-08-19 Pharmaceutical composition containing 3-guanidinopropionic acid and pioglitazone glibenclamide or glimepiride

Publications (1)

Publication Number Publication Date
GR3023848T3 true GR3023848T3 (en) 1997-09-30

Family

ID=27115296

Family Applications (1)

Application Number Title Priority Date Filing Date
GR970401487T GR3023848T3 (en) 1991-08-26 1997-06-19 Pharmaceutical composition containing 3-guanidinopropionic acid and pioglitazone glibenclamide or glimepiride.

Country Status (10)

Country Link
US (1) US5900435A (el)
EP (1) EP0601001B1 (el)
JP (1) JPH06510286A (el)
AT (1) ATE151634T1 (el)
AU (1) AU2479492A (el)
DE (1) DE69219136T2 (el)
DK (1) DK0601001T3 (el)
ES (1) ES2101866T3 (el)
GR (1) GR3023848T3 (el)
WO (1) WO1993003724A1 (el)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU7316591A (en) * 1990-02-28 1991-09-18 Upjohn Company, The Use of 3-guanidinopropionic acid in the treatment and prevention of metabolic disorders
TW438587B (en) * 1995-06-20 2001-06-07 Takeda Chemical Industries Ltd A pharmaceutical composition for prophylaxis and treatment of diabetes
WO1997044324A1 (en) * 1996-05-21 1997-11-27 Pharmacia & Upjohn Company Aminoguanidine carboxylate lactams for the treatment of non-insulin-dependent diabetes mellitus
TR199900056T2 (xx) * 1996-07-12 1999-04-21 Smithkline Beecham P.L.C. Leptin direncinin yeni tedavisi.
US6121288A (en) * 1996-11-08 2000-09-19 Nippon Chemiphar Co., Ltd. Visceral fat lowering agent
US7910548B2 (en) * 1997-06-06 2011-03-22 Amylin Pharmaceuticals, Inc. Methods for treating obesity
US20010049380A1 (en) * 1997-06-18 2001-12-06 Smith Stephen Alistair Treatment of diabetes with thiazolidinedione and sulphonylurea
DE122007000054I1 (de) * 1997-06-18 2007-12-13 Smithkline Beecham Plc Behandlung der Diabetes mit Thiazolidindione und metformin
IL133138A0 (en) * 1997-06-18 2001-03-19 Smithkline Beecham Plc Treatment of diabetes with thiazolidinedione and alpha-glucosidase inhibitor
SK286028B6 (sk) * 1997-06-18 2008-01-07 Smithkline Beecham Plc Farmaceutický prostriedok a jeho použitie
US20020004515A1 (en) * 1997-06-18 2002-01-10 Smith Stephen Alistair Treatment of diabetes with thiazolidinedione and metformin
US20020016287A1 (en) * 1997-07-18 2002-02-07 Smithkline Beecham P.L.C. Treatment of diabetes with thiazolidinedione, insulin secretagogue and diguanide
GB9715295D0 (en) * 1997-07-18 1997-09-24 Smithkline Beecham Plc Novel method of treatment
GB9715306D0 (en) * 1997-07-18 1997-09-24 Smithkline Beecham Plc Novel method of treatment
GB9715298D0 (en) * 1997-07-18 1997-09-24 Smithkline Beecham Plc Novel method of treatment
US6329403B1 (en) 1998-06-30 2001-12-11 Takeda Chemical Industries, Ltd. Pharmaceutical composition for the treatment of diabetes
GB9824893D0 (en) * 1998-11-12 1999-01-06 Smithkline Beckman Corp Novel method of treatment
US20040102486A1 (en) * 1998-11-12 2004-05-27 Smithkline Beecham Corporation Novel method of treatment
US6667064B2 (en) * 2000-08-30 2003-12-23 Pilot Therapeutics, Inc. Composition and method for treatment of hypertriglyceridemia
US9060941B2 (en) 2002-09-20 2015-06-23 Actavis, Inc. Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
US7504118B2 (en) * 2003-04-11 2009-03-17 Fhg Corporation Dietary supplements containing extracts of cinnamon and methods of using same to enhance creatine transport
KR100919323B1 (ko) * 2005-03-19 2009-09-25 정세영 혈중 지질 개선과 항비만 효과를 갖는 신규한 해국지상부위 추출물의 제조 방법 및 이를 함유하는 조성물
WO2012138214A1 (en) * 2011-04-08 2012-10-11 Brewster Lizzy Maritza Beta-guanidinopropionic acid for the treatment of hypertension
IN2015DN03243A (el) * 2012-10-18 2015-10-02 Nissin Foods Holdings Co Ltd
CA3161341A1 (en) * 2019-12-11 2021-06-17 Masoud Fakhr Tavazoie Methods of treating cancer
CN113598232A (zh) * 2021-07-05 2021-11-05 安徽科技学院 一种非发酵凝固型甜酒风味奶及其生产方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1195199A (en) * 1966-11-25 1970-06-17 Horlicks Pharmaceuticals Ltd Improvements in Compositions comprising Insulin.
GB1195200A (en) * 1967-02-07 1970-06-17 Horlicks Pharmaceuticals Ltd Pharmaceutical Compositions.
US3843798A (en) * 1973-03-12 1974-10-22 Stanley Drug Products Inc Methods and compositions for inducing resistance to bacterial infections
GB1552179A (en) * 1976-11-02 1979-09-12 Beecham Group Ltd Pharmaceutical compositions for treating hyperglycaemia
US5053420A (en) * 1989-10-13 1991-10-01 Pershadsingh Harrihar A Thiazolidine derivatives for the treatment of hypertension
IT1237519B (it) * 1989-11-27 1993-06-08 Impiego dell'acido guanidinacetico per indurre un incremento del contenuto muscolare di creatina
GB9003185D0 (en) * 1990-02-13 1990-04-11 Ici Plc Pharmaceutical compositions
AU7316591A (en) * 1990-02-28 1991-09-18 Upjohn Company, The Use of 3-guanidinopropionic acid in the treatment and prevention of metabolic disorders

Also Published As

Publication number Publication date
JPH06510286A (ja) 1994-11-17
US5900435A (en) 1999-05-04
ES2101866T3 (es) 1997-07-16
EP0601001A1 (en) 1994-06-15
ATE151634T1 (de) 1997-05-15
AU2479492A (en) 1993-03-16
WO1993003724A1 (en) 1993-03-04
DE69219136T2 (de) 1997-08-28
DK0601001T3 (da) 1997-10-20
EP0601001B1 (en) 1997-04-16
DE69219136D1 (de) 1997-05-22

Similar Documents

Publication Publication Date Title
GR3023848T3 (en) Pharmaceutical composition containing 3-guanidinopropionic acid and pioglitazone glibenclamide or glimepiride.
Heller Weight gain during insulin therapy in patients with type 2 diabetes mellitus
ATE204178T1 (de) Methode zur behandlung und vorbeugung von typ-1 diabetis durch orale verabreichung von insulin
AU1923088A (en) Piperazinyl derivatives of purines and isosteres thereof as hypoglycemic agents
JPS61148121A (ja) 治療用組成物
DZ1794A1 (fr) Nouvelle formule pharmaceutique.
Schulte-Hermann Two-stage control of cell proliferation induced in rat liver by α-hexachlorocyclohexane
FI971951A0 (fi) 2,2-dikloroalkaanikarboksyylihapot, menetelmät niiden valmistamiseksi, niitä sisältävät lääkkeet, ja niiden käyttö insuliiniresistanssin hoitoon
CA2397294A1 (en) Glyburide composition
HU9401369D0 (en) Human il-4 mutant proteins, thats containing pharmaceutical product and process for producing of proteins
Wechsler Recovery in amyotrophic lateral sclerosis: treated with tocopherols (vitamin E): preliminary report
MXPA04007183A (es) Composicion farmaceutica para el control de la glucosa en sangre de pacientes con diabetes tipo 2.
AU7077096A (en) Selective beta 3 adrenergic agonists
HU200687B (en) Process for producing pharmaceutical composition comprising bezafibrate as active ingredient and suitable for treating normolipidaemic diabetes
Jordan et al. Hunger and satiety in humans during parenteral hyperalimentation
MXPA03003994A (es) Composiciones de metformina de liberacion controlada.
Pincus et al. Dietary method for reducing fluctuations in Parkinson's disease
US3574857A (en) Antilipidemic methods using glutamic acid,threonine and proline
US3928578A (en) Composition for control of white muscle disease
BR9915962A (pt) Composto da série do piridìnio, processos para a preparação de composto da série do piridìnio e de uma formulação parenteral, uso de um composto, composição farmacêutica para tratar complicações diabéticas e doenças associadas ao envelhecimento, e, método para tratar um paciente diabético e para prevenir ou tratar doenças causadas por complicações associadas à diabetes e ao envelhecimento
Walter Clinical impressions on treatment of obsessional states with intravenous clomipramine (Anafranil)
RU94012067A (ru) Средство для лечения осложнений инсулинзависимого и инсулиннезависимого сахарного диабета
JPS6322016A (ja) 免疫刺激剤
US3044932A (en) Appetite suppressant drugs
US3740440A (en) Method of inhibiting appetite for food